BridgeMD
Tests treatment safety and results for Acne
Official title Study to Evaluate the Efficacy, Safety and Tolerability of Photodynamic Therapy(PDT) With Chlorin-e6 in Treating Moderate to Severe Acne
ClinicalTrials.gov ID: NCT06311890
What this study is testing
What is N-chlorin e6 triglumine?
N-chlorin e6 triglumine is an investigational medicine, being studied as a potential treatment for acne.
Also referred to as a red light irradiation.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to evaluate the clinical efficacy, safety and tolerability of a photodynamic therapy(PDT) based on a new photosensitizer, Chlorin-e6, in the treatment of moderate to severe acne. The hypothesis is that the therapy has good efficacy, safety and tolerability.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50
You may be able to join if
- Subject is male or non-pregnant female 18 years of age and younger than 50 years of age.
- Subject has moderate to severe facial acne vulgaris.
- Subject has provided written informed consent.
You likely can't join if
- People who are taking photosensitive drugs;
- Allergic to any component of the photosensitizer;
- porphyrins or allergies to porphyrins, with a history of photosensitivity;
- Pregnant or lactating women and those planning to become pregnant within 3 months;
- Oral or topical antibiotics, retinoids, glucocorticoids, peroxybenzoyl and other drugs within the past 1 month;
- Have a history of exposure to sunlight in the past 1 month, have received photoelectric treatment in the past 3 months, or have received facial...
See the full eligibility criteria
- Subject is male or non-pregnant female 18 years of age and younger than 50 years of age.
- Subject has moderate to severe facial acne vulgaris.
- Subject has provided written informed consent.
- People who are taking photosensitive drugs;
- Allergic to any component of the photosensitizer;
- porphyrins or allergies to porphyrins, with a history of photosensitivity;
- Pregnant or lactating women and those planning to become pregnant within 3 months;
- Oral or topical antibiotics, retinoids, glucocorticoids, peroxybenzoyl and other drugs within the past 1 month;
- Have a history of exposure to sunlight in the past 1 month, have received photoelectric treatment in the past 3 months, or have received facial grinding treatment in the past six months;
- are using vasodilators (such as nitroglycerin, etc.), beta blockers (such as metoprolol, etc.), anticoagulants (such as warfarin, etc.) and other drugs that easily cause facial capillary dilatation;
- Patients with facial rosacea, atopic dermatitis, hormone-dependent dermatitis and other facial skin-related diseases;
- Abnormal blood and urine routine, liver and kidney function, diseases of important organs and hematopoietic system that researchers believe are not suitable for clinical trials;
- Patients participating in other clinical trials at the same time.
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.